Antioncogene P53 and mitogenic cytokine interleukin-8 aberrantly expressed in psoriatic skin are inversely regulated by the antipsoriatic drug tacrolimus (FK506)

Biochemical Pharmacology

Volumn 51, Issue 10, 1996, Pages 1315-1320

  Michel, Günter ^a   Auer, Hans ^a   Kemény, Lajos ^b   Böcking, Alfred ^a   Ruzicka, Thomas ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

antipsoriatic compound; drug effects; gene expression; growth regulators

Indexed keywords

ANTIPSORIASIS AGENT; CYTOKINE; INTERLEUKIN 8; MESSENGER RNA; MITOGENIC AGENT; PROTEIN P53; TACROLIMUS;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPIDERMIS CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; PSORIASIS; RNA TRANSLATION; SIGNAL TRANSDUCTION;

EID: 0029881214     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00039-1     Document Type: Article

References (23)

1. Rosenbach T and Czarnetzki B, Signal transduction pathways in keracinocytes. Exp Dermatol 1: 59-66, 1992.
2. Menter A and Barker JN, Psoriasis in practice. Lancet 338: 231-234, 1991.
3. Rothe M and Falanga V, Growth Factors. Arch Dermatol 125: 1390-1398, 1989.
4. Christophers E, Schröder JM and Mroweitz U, Identification of two endogenous neutrophil-activating peptides in psoriatic skin and inflammatory cells: C5ades arg and NAP. Dermatologica 179 Suppl 1: 9-15, 1989.
5. Meingassner JG and Stütz A, Immunosuppressive macrolides of the type FK506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 6: 851-855, 1992.
6. Jegasothy BV, Ackerman CD, Todo S, Fung JJ, Abu Elmagd K and Starzl TE, Tacrolimus (FK506) - a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol 128: 781-785, 1992.
7. Schreiber SL and Crabtree GR, The mechanism of action of cyclosporin A and FK506. Immunol Today 13: 136-142, 1992.
8. Arenberger P, Kemény L and Ruzicka T, Characterization of high-affinity 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding sites on normal human keratinocytes. Epith Cell Biol 2: 1-6, 1993.
9. Michel G, Kemény L, Peter RU, Beetz A, Ried C, Arenberger P and Ruzicka T, Interleukin-8 receptor-mediated chemotaxis of normal human epidermal cells. FEBS Lett 305: 241-243, 1992.
10. Arenberger P, Kemény L, and Ruzicka T, Defect of epidermal 12(S)-hydroxyeicosatetraenoic acid receptors in psoriasis. Eur J Clin Invest 22: 235-243, 1992.
11. Schulz BS, Michel G, Wagner S, Süss R, Beetz A, Peter RU, Kemény L and Ruzicka T, Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. J Immunol 151: 4399-4406, 1993.
12. Süss R, Arenberger P, Gross EC and Ruzicka T, Regulation of 12(S)-hydroxyeicosa-tetraenoic acid (12(S)-HETE) binding sites on human epidermal cells by interferon-gamma. Exp Cell Res 191: 204-208, 1990.
13. Coussens L, Yang Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, et al., Tyrosine kinase receptor with extensive homology to EGF receptor share chromosomal location with neu oncogene. Science 230: 1132-1139, 1985.
14. Capon DJ, Chen EY, Levinson AD, Seeburg PH and Goeddel DV, Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature 302: 33-37, 1983.
15. Bonner TI, Oppermann H, Seeburg P, Kerby SB, Gunnell MA, Young AC and Rapp UR, The complete coding sequence of the human raf oncogene and the corresponding structure of the c-raf-1 gene. Nucleic Acids Res 14: 1009-1015, 1986.
16. Zakut-Houri R, Bienz Tadmor B, Givol D and Oren M, Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. EMBO J 4: 1251-1255, 1985.
17. Matsushima K and Oppenheim JJ, Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1: 2-12, 1989.
18. Taniguchi T, Matsui H, Fujita T, Takaoka C, Kashima N, Yoshimoto R and Hamuro J, Structure and expression of a cloned cDNA for human interleukin-2. Nature 302: 305-310, 1983.
19. Nakajima-Iijima S, Hamada H, Reddy P and Kakunaga T, Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 82: 6133-6137, 1985.
20. Wilkinson M, Doskow J and Lindsey S, RNA blots: staining procedures and optimization of conditions. Nucleic Acids Res 19: 679, 1990.
21. Kemény L, Kenderessy AS, Olasz E, Michel G, Ruzicka T and Dobozy A, The interleukin-8 receptor: a potential target for antipsoriatic therapy. Eur J Pharmacol 258: 269-272, 1994.
22. Lemster BH, Carroll PB, Rilo HR, Nikaein A and Thomson AW, IL8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy. Clin Exp Immunol 99: 148-154, 1995.
23. Healy E, Reynolds NJ, Smith MD, Campbell C, Far PM and Rees JL, Dissociation of erythema and p53 protein expression in human skin following UVB irradiation, and induction of p53 protein and mRNA following application of skin irritants. J Invest Dermatol 103: 493-499, 1994.